@davidfajgenbaum : When a drug receives FDA approval, its research and development (R&D) often shifts away from further exploration into new indications. It's a common misconception that approval marks the peak of a drug's journey. In reality, it’s the opposite. When the drug eventually turns • TwiCopy

David Fajgenbaum, MD

@davidfajgenbaum

+ Follow

@Penn physician-scientist-patient who 'cured thyself' | Advancing @CureCastleman + @EveryCure | National Bestseller #ChasingMyCure ChasingMyCure.com

ID: 340440727

linkhttp://amazon.com/Chasing-My-Cure-Doctors-Action/dp/1524799637 calendar_today22-07-2011 18:11:10

3,3K Tweet

11,11K Followers

2,2K Following

David Fajgenbaum, MD

@davidfajgenbaum

a year ago

When a drug receives FDA approval, its research and development (R&D) often shifts away from further exploration into new indications. It's a common misconception that approval marks the peak of a drug's journey. In reality, it’s the opposite. When the drug eventually turns

thumb_up_off_alt49

chat_bubble_outline10

repeat7

shareShare